Biotech Force Danmark ApS
CVR number: 36434309
Gl. Donsvej 6, Bramdrupdam 6000 Kolding
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | - 485.00 | -1 484.55 | -1 879.45 | -2 965.17 | -2 418.68 |
| Other operating expenses | -9 391.84 | ||||
| Total depreciation | - 547.07 | - 593.14 | - 661.01 | ||
| EBIT | -1 032.07 | -2 077.70 | -2 540.46 | -2 965.17 | -11 810.52 |
| Other financial income | 55.60 | 12.71 | 0.01 | 55.57 | |
| Other financial expenses | - 269.23 | - 439.69 | - 381.51 | - 505.71 | - 618.45 |
| Pre-tax profit | -1 245.69 | -2 517.39 | -2 909.26 | -3 470.87 | -12 373.39 |
| Income taxes | 274.20 | 586.04 | 643.75 | 774.63 | 650.23 |
| Net earnings | - 971.50 | -1 931.35 | -2 265.51 | -2 696.24 | -11 723.16 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 610.44 | 519.60 | |||
| Intangible assets total | 610.44 | 519.60 | |||
| Land and waters | 17 287.29 | 16 974.77 | 16 575.77 | ||
| Buildings | 2 735.74 | 2 564.56 | 2 393.38 | ||
| Tangible assets total | 20 023.02 | 19 539.33 | 18 969.15 | ||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 6 128.73 | 6 631.42 | 10 508.26 | 10 223.96 | |
| Inventories total | 6 128.73 | 6 631.42 | 10 508.26 | 10 223.96 | |
| Current trade debtors | 2.62 | 5 301.96 | 5 301.96 | 4 528.49 | 2 360.10 |
| Current amounts owed by group member comp. | 1 900.71 | 1 849.22 | 1 312.53 | 564.98 | |
| Current other receivables | 818.41 | 2 018.89 | 270.34 | 566.16 | 730.04 |
| Current deferred tax assets | 579.40 | 676.65 | 676.65 | 129.23 | |
| Short term receivables total | 1 400.43 | 9 898.22 | 8 098.18 | 6 407.18 | 3 784.35 |
| Cash and bank deposits | 108.04 | 134.56 | |||
| Cash and cash equivalents | 108.04 | 134.56 | |||
| Balance sheet total (assets) | 21 423.45 | 36 176.72 | 34 218.35 | 17 023.48 | 14 142.87 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 1 050.00 | 1 050.00 | 1 050.00 | 1 050.00 |
| Asset revaluation reserve | 5 839.08 | 5 676.92 | 5 514.72 | ||
| Other reserves | 476.14 | 476.14 | |||
| Retained earnings | 654.20 | - 631.27 | -2 400.43 | 1 324.92 | -1 371.32 |
| Profit of the financial year | - 971.50 | -1 931.35 | -2 265.51 | -2 696.24 | -11 723.16 |
| Shareholders equity total | 5 571.78 | 4 640.44 | 2 374.92 | - 321.32 | -12 044.48 |
| Provisions | 2 317.00 | 2 465.00 | 1 821.25 | 521.00 | 7 479.06 |
| Non-current loans from credit institutions | 6 602.38 | 6 264.62 | 5 924.92 | ||
| Non-current liabilities total | 6 602.38 | 6 264.62 | 5 924.92 | ||
| Current loans from credit institutions | 2 880.77 | 4 466.39 | 4 467.35 | 2.87 | |
| Current trade creditors | 25.00 | 2 212.97 | 59.13 | 922.56 | 25.09 |
| Current owed to group member | 4 026.53 | 16 127.30 | 19 570.78 | 14 913.31 | 18 683.19 |
| Short-term deferred tax liabilities | 985.07 | ||||
| Current liabilities total | 6 932.30 | 22 806.66 | 24 097.26 | 16 823.80 | 18 708.29 |
| Balance sheet total (liabilities) | 21 423.45 | 36 176.72 | 34 218.35 | 17 023.48 | 14 142.87 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.